Prostate Adenocarcinoma, TMPRSS2::ETV1 Fusion-Positive: Two Cases with Clinical and Molecular Characterization

被引：0
|
作者：
Bubar, R. [1 ]
Korentzelos, D. [1 ]
Wald, A. [1 ]
Tucker, J. [1 ]
Mohebnasab, M. [1 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2024年 / 26卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
ST130
引用
收藏
页码：S133 / S133
页数：1
相关论文
共 50 条
  • [21] Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: Molecular evidence for an independent group of diseases
    Mehra, Rohit
    Han, Bo
    Tomlins, Scott A.
    Wang, Lei
    Menon, Anjana
    Wasco, Matthew J.
    Shen, Ronglai
    Montie, James E.
    Chinnaiyan, Arul M.
    Shah, Rajal B.
    CANCER RESEARCH, 2007, 67 (17) : 7991 - 7995
  • [22] Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma:: Molecular evidence for an independent group of diseases
    Mehra, R.
    Han, B.
    Tomlins, S. A.
    Wang, L.
    Menon, A.
    Wasco, M.
    Shen, R.
    Montie, J. E.
    Chinniayan, A. M.
    Shah, R. B.
    MODERN PATHOLOGY, 2008, 21 : 170A - 170A
  • [23] Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma:: Molecular evidence for an independent group of diseases
    Mehra, R.
    Han, B.
    Tomlins, S. A.
    Wang, L.
    Menon, A.
    Wasco, M.
    Shen, R.
    Montie, J. E.
    Chinniayan, A. M.
    Shan, R. B.
    LABORATORY INVESTIGATION, 2008, 88 : 170A - 170A
  • [24] TMPRSS2:ERG Fusion Positive and TMPRSS2:ERG Wild Type Relapsed and Metastatic Castrate Resistant Prostate Cancer Differ in Genomic Signatures and Opportunities for Targeted and Immunotherapies
    Gay, Laurie
    Chung, Jon
    Elvin, Julia A.
    Vergilio, Jo-Anne
    Suh, James
    Severson, Eric
    Ramkissoon, Shakti
    Daniel, Sugganth
    Ali, Siraj
    Frampton, Garrett M.
    Hartmaier, Ryan
    Albacker, Lee
    Schrock, Alexa B.
    Miller, Vincent A.
    Stephens, Philip M.
    Ross, Jeffrey S.
    MODERN PATHOLOGY, 2018, 31 : 341 - 342
  • [25] TMPRSS2: ERG Fusion Positive and TMPRSS2: ERG Wild Type Relapsed and Metastatic Castrate Resistant Prostate Cancer Differ in Genomic Signatures and Opportunities for Targeted and Immunotherapies
    Gay, Laurie
    Chung, Jon
    Elvin, Julia A.
    Vergilio, Jo-Anne
    Suh, James
    Severson, Eric
    Ramkissoon, Shakti
    Daniel, Sugganth
    Ali, Siraj
    Frampton, Garrett M.
    Hartmaier, Ryan
    Albacker, Lee
    Schrock, Alexa B.
    Miller, Vincent A.
    Stephens, Philip M.
    Ross, Jeffrey S.
    LABORATORY INVESTIGATION, 2018, 98 : 341 - 342
  • [26] TMPRSS2:ERG fusion and SPINK1 expression in endocrine treated prostate cancer
    Leinonen, K. A.
    Tolonen, T. T.
    Bracken, H.
    Stenman, U-H.
    Tammela, T. L. J.
    Saramaki, O. R.
    Visakorpi, T.
    INTERNATIONAL JOURNAL OF ANDROLOGY, 2010, 33 : 94 - 94
  • [27] CASTRATE RESISTANT TMPRSS2: ERG FUSION POSITIVE AND TMPRSS2: ERG WILD TYPE REFRACTORY ACINAR AND NEUROENDOCRINE PROSTATE CANCER DIFFER IN GENOMIC SIGNATURES AND OPPORTUNITIES FOR TARGETED AND IMMUNOTHERAPIES
    Liu, Nick
    Fisher, Hugh A. G.
    Byler, Timothy
    Jacob, Joseph
    Chung, Jon
    Elvin, Julia Andrea
    Vergilio, Jo-Anne
    Ramkissoon, Shakti
    Suh, James
    Severson, Eric Allan
    Daniel, Sugganth
    Ali, Siraj Mahamed
    Schrock, Alexa Betzig
    Miller, Vincent A.
    Stephens, Philip J.
    Gay, Laurie M.
    Kotula, Leszek
    Ross, Jeffrey S.
    Bratslavsky, Gennady
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1145 - E1146
  • [28] Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status
    J L Wright
    L Chéry
    S Holt
    D W Lin
    M Luedeke
    A E Rinckleb
    C Maier
    J L Stanford
    Prostate Cancer and Prostatic Diseases, 2016, 19 : 53 - 56
  • [29] Exploring therapeutic applications of PTEN, TMPRSS2:ERG fusion, and tumour molecular subtypes in prostate cancer management
    Bugoye, Fidelis Charles
    Torrorey-Sawe, Rispah
    Biegon, Richard
    Dharsee, Nazima
    Mafumiko, Fidelice
    Kibona, Herry
    Aboud, Said
    Patel, Kirtika
    Mining, Simeon
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [30] Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status
    Wright, J. L.
    Chery, L.
    Holt, S.
    Lin, D. W.
    Luedeke, M.
    Rinckleb, A. E.
    Maier, C.
    Stanford, J. L.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2016, 19 (01) : 53 - 56
12345